Philippe Alen, PhD, is Vice President and Head of Business Development, Licensing and Alliance Management for Cardiovascular Diseases at Bayer Pharmaceuticals. He has over 20 years of experience across biopharma R&D, global marketing and business development.
At Bayer, Dr. Alen is responsible for all partnering activities for cardiology, nephrology and adjacent disease states, from early stage research and technologies to late development, alliance management, and commercial products.
Prior to joining Bayer, he was responsible for Business Development at Janssen Pharmaceuticals, a Johnson & Johnson company, in the Infectious Disease and Vaccines therapeutic area.
Dr. Alen holds a Pharm.D. and Ph.D. from the Catholic University of Leuven, Belgium, and MBA from Drexel University, USA.